Skip to main content

RETRACTION

Pathol. Oncol. Res., 14 December 2023
Volume 29 - 2023 | https://doi.org/10.3389/pore.2023.1611617

Retraction: Associations of porphyromonas gingivalis infection and low beclin1 expression with clinicopathological parameters and survival of esophageal squamous cell carcinoma patients

Pathology and Oncology Research Editorial Office Pathology and Oncology Research Editorial Office*
  • Frontiers Media SA, Lausanne, Switzerland

A Retraction of the Original Research Article
Associations of porphyromonas gingivalis infection and low beclin1 expression with clinicopathological parameters and survival of esophageal squamous cell carcinoma patients

by Guo Y, Liu Y, Yang H, Dai N, Zhou F, Yang H, Sun W, Kong J, Yuan X and Gao S (2021). Pathol. Oncol. Res. 27:1609976. doi: 10.3389/pore.2021.1609976

The journal retracts the 08 December 2021 article cited above.

Following publication, concerns were raised regarding data misrepresentation. In particular, multiple discrepancies were identified in the flow cytometry graphs, western blots and bar graphs in Figure 4. Following provision of raw data by the authors, the Editor in Chief concluded that the article’s conclusions and assertions were not sufficiently supported by the findings from the material provided; therefore, the article has been retracted. The authors do not agree to this retraction.

Citation: Pathology and Oncology Research Editorial Office (2023) Retraction: Associations of porphyromonas gingivalis infection and low beclin1 expression with clinicopathological parameters and survival of esophageal squamous cell carcinoma patients. Pathol. Oncol. Res. 29:1611617. doi: 10.3389/pore.2023.1611617

Received: 30 November 2023; Accepted: 05 December 2023;
Published: 14 December 2023.

Approved by:

Pathology and Oncology Research Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2023 Pathology and Oncology Research Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Pathology and Oncology Research Editorial Office, editorialoffice@por-journal.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.